Eleven upregulated pathways (Figure 6(a)) that included cell cycle, viral carcinogenesis, chronic myeloid leukemia, and p53 signaling pathway were identified in both HCHD and ECHD groups. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.